diogenes helpfully calculated that about 10,000 UK patients receive liothyronine - 0.7% of those who are hypothyroid.
This is a depressingly low figure. It set me to wondering what the prescribing rates are in those countries with high quality locally manufactured liothyronine. Obvious examples would include Germany, France and Greece.
Does ready access at a sensible price, together with differently trained endocrinologists make a big difference? Or are the rates similarly low everywhere?
I think we have to include T4 + T3 combination products - they are just a convenient way of getting some T3 along with T4. We in the UK do not have any such products - which is why this comment seemed important.
I am not bad at web searching but sometimes trying to work out precisely what is meant in a foreign language isn't easy.